Skip to content
Ordering closed
CAT. PG-RETA-030Pre-launch

Retatrutide 30mg

Retatrutide is a synthetic investigational peptide with agonist activity at three receptors: GIP, GLP-1 and glucagon.

Listed single-vial price$139.00

Ordering closed

Ordering is not open

PepGo is not accepting orders while its controlled pre-launch checks are in progress.

We only use this email to tell you when ordering opens.

Catalog status

8 listed sizes in this reagent class.

Browse Incretin receptor agonist peptides

Record

Specification

CAS and molecular-weight records describe a chemical identity; they are not a lot-specific test result.

Catalog number
PG-RETA-030
CAS reference
2381089-83-2
Molecular weight
4,845.4 g/mol
Form
Lyophilized powder
Size
30mg
Storage
-20°C, protect from light
Purity
No result published yet
Lot certificate
None published yet

Research context

Triple GIP/GLP-1/glucagon receptor agonist reference peptide

Used in laboratory receptor-binding assays as the triple-agonist reference in comparisons with dual- and single-receptor peptides.

Storage & handling

Storage
Store sealed at -20°C, protected from light and moisture, until laboratory use. Reseal and return to cold storage promptly after handling.
Handling
Supplied as a lyophilized powder intended for in-vitro laboratory use. Handle with standard laboratory PPE and technique appropriate to the experiment.
Stability
No lot-specific stability record is published. Researchers must assess the material received under their own in-vitro conditions.

Structural references

Reference-only source records do not verify material from a particular lot.

  1. [1]PubChem: Substance SID 438519203, Retatrutide (CAS 2381089-83-2) (opens in a new tab)

Research Use Only

This product is a chemical reagent for in-vitro laboratory research only. It is not for human or veterinary use of any kind, or for any diagnostic or clinical application.

Questions about this record

For Research Use Only. Not for human or veterinary use. Products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.